![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients The Case for Outsourcing Peptides Manufacture2:03 AM MDT | August 26, 2010 An article by the American Peptide Company (Sunnyvale, CA) These days, many companies facing increasing pressure, to reduce costs, risk, and time-to-market, and maximize efficiencies, have converged on a similar strategy: outsource non-core functions. This is why companies as small as start-up biotechs and as large as the pharmaceutical and biopharmaceutical majors, outsource peptide production needs ever more increasingly. Whether a company needs research-grade materials or GMP-grade materials, they are realizing cost effectiveness and efficiency by... This information is only available to Chemical Week subscribers. Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|